Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 6, 2023 22:26 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 46,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-029100 · tm238642-3_4seq1.xml · derivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,875 Underlying: Common Stock · 46,875 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:27 UTC |
Vogt Frederick GSee Remarks
|
GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001104659-23-029101 · tm238642-4_4seq1.xml · derivative · entry 2 Vogt Frederick G · CIK 0001719678 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-03-02 F3 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:27 UTC |
Vogt Frederick GSee Remarks
|
GrantRestricted Stock Units · Derivative | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-029101 · tm238642-4_4seq1.xml · derivative · entry 1 Vogt Frederick G · CIK 0001719678 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:25 UTC |
BILINSKY IGORChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 84,380 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001104659-23-029098 · tm238642-2_4seq1.xml · derivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,380 Underlying: Common Stock · 84,380 shares Expires 2033-03-02 F3 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:25 UTC |
BILINSKY IGORChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 42,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-029098 · tm238642-2_4seq1.xml · derivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,190 Underlying: Common Stock · 42,190 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 22:24 UTC |
Bellemin Jean-MarcChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 168,750 | $0.00 Strike: $7.12 | $0.00 |
DisclosureSEC source: 0001104659-23-029093 · tm238642-1_4seq1.xml · derivative · entry 1 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,750 Underlying: Common Stock · 168,750 shares Expires 2033-03-02 F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the options are exercisable as follows: (i) options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:52 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 11,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-005048 · tm233853d3_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,502 Underlying: Common stock · 11,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in eight equal quarterly installments over the next two years. F5 · derivative.expiration_date: The remaining RSUs will vest in eight equal quarterly installments over the next two years. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:52 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 4,678 | $6.43 | $30,079.54 |
DisclosureSEC source: 0001104659-23-005048 · tm233853d3_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,118 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:52 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 11,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-005048 · tm233853d3_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: One-third of the restricted stock units ("RSUs") issued to the Reporting Person on January 14, 2022, vested on January 14, 2023. The vested RSUs were settled on January 17, 2023. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:51 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 83,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-005045 · tm233853d1_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,675 Underlying: Common stock · 83,325 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in eight equal quarterly installments over the next two years. F5 · derivative.expiration_date: The remaining RSUs will vest in eight equal quarterly installments over the next two years. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:51 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Tax withholdingCommon Stock | 36,441 | $6.43 | $234,315.63 |
DisclosureSEC source: 0001104659-23-005045 · tm233853d1_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,884 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:51 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
Exercise / conversionCommon Stock | 83,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-005045 · tm233853d1_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: One-third of the restricted stock units ("RSUs") issued to the Reporting Person on January 14, 2022, vested on January 14, 2023. The vested RSUs were settled on January 17, 2023. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:52 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 11,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-005046 · tm233853d2_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,502 Underlying: Common stock · 11,248 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in eight equal quarterly installments over the next two years. F5 · derivative.expiration_date: The remaining RSUs will vest in eight equal quarterly installments over the next two years. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:52 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 4,671 | $6.43 | $30,034.53 |
DisclosureSEC source: 0001104659-23-005046 · tm233853d2_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,378 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 21:52 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 11,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-005046 · tm233853d2_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: One-third of the restricted stock units ("RSUs") issued to the Reporting Person on January 14, 2022, vested on January 14, 2023. The vested RSUs were settled on January 17, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:57 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 19,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001607 · tm232380d3_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 19,690 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023. F5 · derivative.expiration_date: As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:57 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 11,023 | $6.11 | $67,350.53 |
DisclosureSEC source: 0001104659-23-001607 · tm232380d3_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,548 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:57 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 19,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001607 · tm232380d3_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This is the second and final vesting of the restricted stock units ("RSUs") issued on June 14, 2021. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:45 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001601 · tm232380d2_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 18,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023. F5 · derivative.expiration_date: As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:45 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 10,553 | $6.11 | $64,478.83 |
DisclosureSEC source: 0001104659-23-001601 · tm232380d2_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,801 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:45 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001601 · tm232380d2_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This is the second and final vesting of the restricted stock units ("RSUs") issued on June 14, 2021. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:45 UTC |
Bellemin Jean-MarcChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001600 · tm232380d1_4seq1.xml · derivative · entry 3 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 18,850 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023. F6 · derivative.expiration_date: As of December 31, 2022, the remaining RSUs have fully vested and were settled on January 3, 2023. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:45 UTC |
Bellemin Jean-MarcChief Financial Officer
|
Tax withholdingCommon Stock | 10,553 | $6.11 | $64,478.83 |
DisclosureSEC source: 0001104659-23-001600 · tm232380d1_4seq1.xml · nonDerivative · entry 2 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,801 F3 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F4 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| January 03, 2023 Filed Jan 6, 2023 01:45 UTC |
Bellemin Jean-MarcChief Financial Officer
|
Exercise / conversionCommon Stock | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-001600 · tm232380d1_4seq1.xml · nonDerivative · entry 1 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This is the second and final vesting of the restricted stock units ("RSUs") issued on June 14, 2021. F2 · balance_after: Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan. Read SEC document |
| December 21, 2022 Filed Dec 22, 2022 21:06 UTC |
MCPEAK MERRILL ADirector
|
PurchaseCommon Stock | 10,000 | $6.15 | $61,500.00 |
DisclosureSEC source: 0001104659-22-129516 · tm2233363-1_4seq1.xml · nonDerivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,150 Read SEC document |
| December 02, 2022 Filed Dec 2, 2022 22:29 UTC |
Rothbaum Wayne P.Director
|
PurchaseCommon Stock | 10,000,000 | $6.50 | $65,000,000.00 |
DisclosureSEC source: 0001104659-22-124196 · tm2231927-1_4seq1.xml · nonDerivative · entry 1 Rothbaum Wayne P. · CIK 0001423102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quogue Capital LLC Disclosed balance after: 18,067,333 F2 · balance_after: The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC. F1 · ownership.nature: Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer. Read SEC document |
| November 29, 2022 Filed Nov 30, 2022 21:17 UTC |
MCPEAK MERRILL ADirector
|
PurchaseCommon Stock | 10,000 | $6.31 | $63,100.00 |
DisclosureSEC source: 0001104659-22-123244 · tm2231611-1_4seq1.xml · nonDerivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 238,633 F1 · ownership.nature: These shares are held by a family trust for which the reporting person is a trustee. Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 02:46 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
PurchaseCommon Stock | 1,000 | $5.98 | $5,980.00 |
DisclosureSEC source: 0001104659-22-122556 · tm2231429-2_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| November 28, 2022 Filed Nov 29, 2022 02:44 UTC |
MCPEAK MERRILL ADirector
|
PurchaseCommon Stock | 10,000 | $6.18 | $61,800.00 |
DisclosureSEC source: 0001104659-22-122555 · tm2231429-3_4seq1.xml · nonDerivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 228,633 F1 · ownership.nature: These shares are held by a family trust for which the reporting person is a trustee. Read SEC document |
| November 23, 2022 Filed Nov 29, 2022 02:43 UTC |
Dukes Iain D.Director
|
PurchaseCommon Stock | 10,000 | $6.10 | $61,000.00 |
DisclosureSEC source: 0001104659-22-122554 · tm2231429-1_4seq1.xml · nonDerivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:15 UTC |
MCPEAK MERRILL ADirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001104659-22-094430 · tm2224516-1_4seq1.xml · derivative · entry 3 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2023-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents an exercise of stock options and hold of underlying shares. Read SEC document |
| August 23, 2022 Filed Aug 25, 2022 20:15 UTC |
MCPEAK MERRILL ADirector
|
Exercise / conversionCommon Stock | 40,000 | $5.65 | $226,000.00 |
DisclosureSEC source: 0001104659-22-094430 · tm2224516-1_4seq1.xml · nonDerivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents an exercise of stock options and hold of underlying shares. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:04 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 19,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071967 · tm2218629-3_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,690 Underlying: Common stock · 19,690 shares Expires not disclosed F4 · security: Represents restricted stock units remaining after deducting the vested shares of common stock and the common stock withheld for taxes as set forth in Table I above. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date. F6 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:04 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 6,809 | $7.73 | $52,633.57 |
DisclosureSEC source: 0001104659-22-071967 · tm2218629-3_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,881 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:04 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 19,690 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071967 · tm2218629-3_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,690 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This is the first vesting of the restricted stock units issued on June 14, 2021. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:03 UTC |
Bellemin Jean-MarcChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071965 · tm2218629-2_4seq1.xml · derivative · entry 3 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850 Underlying: Common stock · 18,850 shares Expires not disclosed F5 · security: Represents restricted stock units remaining after deducting the vested shares of common stock and common stock withheld for taxes as set forth in Table I above. F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F7 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date. F7 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:03 UTC |
Bellemin Jean-MarcChief Financial Officer
|
Tax withholdingCommon Stock | 9,346 | $7.73 | $72,244.58 |
DisclosureSEC source: 0001104659-22-071965 · tm2218629-2_4seq1.xml · nonDerivative · entry 2 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,504 F3 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F4 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:03 UTC |
Bellemin Jean-MarcChief Financial Officer
|
Exercise / conversionCommon Stock | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071965 · tm2218629-2_4seq1.xml · nonDerivative · entry 1 Bellemin Jean-Marc · CIK 0001754253 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This is the first vesting of the restricted stock units issued on June 14, 2021. F2 · balance_after: Represents common stock owned by the Reporting Person, excluding common stock purchased pursuant to the Issuer's 2020 Employee Stock Purchase Plan. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:03 UTC |
BILINSKY IGORChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071964 · tm2218629-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850 Underlying: Common stock · 18,850 shares Expires not disclosed F4 · security: Represents restricted stock units remaining after deducting the vested shares of common stock and common stock withheld for taxes as set forth in Table I above. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F6 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date. F6 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on December 31, 2022, the remaining restricted stock units shall vest and be settled on such date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:03 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 9,346 | $7.73 | $72,244.58 |
DisclosureSEC source: 0001104659-22-071964 · tm2218629-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,504 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 21:03 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 18,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071964 · tm2218629-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This is the first vesting of the restricted stock units issued on June 14, 2021. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 21:03 UTC |
MCPEAK MERRILL ADirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071055 · tm2218366-6_4seq1.xml · derivative · entry 1 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,204 Underlying: Common Stock · 51,204 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 21:03 UTC |
Countouriotis AthenaDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071056 · tm2218366-7_4seq1.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,204 Underlying: Common Stock · 51,204 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 21:02 UTC |
Maynard Ryan DDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071054 · tm2218366-5_4seq1.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,204 Underlying: Common Stock · 51,204 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 21:02 UTC |
WEISER MICHAELDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071053 · tm2218366-4_4seq1.xml · derivative · entry 1 WEISER MICHAEL · CIK 0001221449 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,204 Underlying: Common Stock · 51,204 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 21:01 UTC |
Dukes Iain D.Director
|
GrantDeferred Restricted Stock Unit · Derivative | 102,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071051 · tm2218366-3_4seq1.xml · derivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,409 Underlying: Common Stock · 102,409 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 10, 2022 Filed Jun 14, 2022 21:01 UTC |
DIXON WENDY LDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 51,204 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-071050 · tm2218366-2_4seq1.xml · derivative · entry 1 DIXON WENDY L · CIK 0001202283 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,204 Underlying: Common Stock · 51,204 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 00:00 UTC |
Vogt Frederick GInterim CEO & General Counsel
|
PurchaseCommon Stock | 1,000 | $6.44 | $6,440.00 |
DisclosureSEC source: 0001104659-22-067758 · tm2217576d2_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Interim CEO & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 23:59 UTC |
Rothbaum Wayne P.Director
|
PurchaseCommon Stock | 500,000 | $6.43 | $3,215,500.00 |
DisclosureSEC source: 0001104659-22-067757 · tm2217576d1_4.xml · nonDerivative · entry 2 Rothbaum Wayne P. · CIK 0001423102 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Quogue Capital LLC Disclosed balance after: 8,067,333 F2 · balance_after: The numbers reported in column 5 exclude 1,932,667 shares of common stock underlying 1,932,667 shares of Series B Preferred Stock of the Issuer beneficially owned by Quogue Capital LLC. F1 · ownership.nature: Such shares may be held directly by Quogue Capital LLC or are held by one or more entities controlled by Quogue Capital LLC. The reporting person is the sole managing member of Quogue Capital LLC, and therefore, he is deemed to beneficially own such shares of common stock of the Issuer. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 00:03 UTC |
MCPEAK MERRILL ADirector
|
PurchaseCommon Stock | 10,000 | $6.80 | $68,000.00 |
DisclosureSEC source: 0001104659-22-067763 · tm2217576d5_4seq1.xml · nonDerivative · entry 2 MCPEAK MERRILL A · CIK 0001210317 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 218,633 F2 · ownership.nature: These shares are held by a family trust for which the reporting person is a trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.